Our Clients
While the needs of each client differ, the fundamentals of creative conception, strategic planning, professional execution and results that return the client’s investment define every project. This commitment is underscored not only by the number of companies which MCS has supported since 1985, but also by the long tenure of our relationships with many of these clients.
 |
Adams Respiratory Therapeutics |
|
 |
Auxilium Pharmaceuticals |
|
 |
BD |
|
 |
 |
CSL Behring |
 |
Genentech |
|
 |
Qforma |
|
 |
Regeneron Pharmaceuticals |
|
 |
Schering-Plough |
|
 |
Synergetics USA |
CSL Behring
Profile
MCS provides communication support to CSL Behring for Humate-P for the treatment of von Willebrand disease and C1-inhibitor concentrate, an investigational treatment for hereditary angioedema.
CSL Behring is a global leader in the plasma protein biotherapeutics industry. Dedicated to improving the quality of life for patients throughout the world, ZLB Behring provides safe and effective plasma-derived and recombinant products and offers patients a wide range of related services. The company's broad portfolio of life-saving therapeutics is used in the treatment of individuals with hemophilia and other bleeding disorders, immune deficiency disorders, and inherited emphysema; for the prevention of hemolytic diseases for the newborn; in cardiac surgery patients; and in shock and burn victims.
For more information on CSL Behring, please visit the company's web site at www.cslbehring.com.